Literature DB >> 20551295

Cellular and molecular mechanisms of photodynamic hypericin therapy for nasopharyngeal carcinoma cells.

Xiaoli Wang1, Yi Guo, Shu Yang, Caihong Wang, Xuping Fu, Jinling Wang, Yumin Mao, Junsong Zhang, Yao Li.   

Abstract

Hypericin-mediated photodynamic therapy (HY-PDT) has become a potential treatment for tumors and nonmalignant disorders. Some studies reported that HY-PDT could lead to apoptosis in some carcinoma cells. However, the molecular mechanism of HY-PDT remains unknown. In this study, we evaluated the molecular mechanisms of hypericin associated with light-emitting diode irradiation on the poorly differentiated human nasopharyngeal carcinoma cell line CNE-2 in vitro. To comprehensively understand the effects of HY-PDT on CNE-2 cells, we detected cell viability, cell cycle, apoptosis, intracellular glutathione content, and intracellular caspase (caspase-9, caspase-3, and caspase-8) activity. Furthermore, we performed genome-wide expression analysis via microarrays at different time points in response to HY-PDT, and we found that differentially expressed genes were highly enriched in the pathways related to reactive oxygen species generation, mitochondrial activity, DNA replication and repair, cell cycle/proliferation, and apoptosis. These results were consistent with our cytology test results and demonstrated that caspase-dependent apoptosis occurred after HY-PDT. Taken together, both cellular and molecular data revealed that HY-PDT could inhibit the growth of CNE-2 cells and induce their apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20551295     DOI: 10.1124/jpet.110.168856

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Photosensitizing effects of hypericin on head neck squamous cell carcinoma in vitro.

Authors:  Wiebke Laffers; Ann-Christin Busse; Jens Mahrt; Phuc Nguyen; Andreas O H Gerstner; Friedrich Bootz; Johannes T Wessels
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-01       Impact factor: 2.503

2.  Cationic ceramides and analogues, LCL30 and LCL85, as adjuvants to photodynamic therapy of tumors.

Authors:  Mladen Korbelik; Wei Zhang; Kyi Min Saw; Zdzislaw M Szulc; Alicja Bielawska; Duska Separovic
Journal:  J Photochem Photobiol B       Date:  2013-07-06       Impact factor: 6.252

3.  The efficacy and mechanism of apoptosis induction by hypericin-mediated sonodynamic therapy in THP-1 macrophages.

Authors:  Xuesong Li; Lei Gao; Longbin Zheng; Jiayuan Kou; Xing Zhu; Yueqing Jiang; Zhaoyu Zhong; Juhua Dan; Haobo Xu; Yang Yang; Hong Li; Sa Shi; Wenwu Cao; Yajun Zhao; Ye Tian; Liming Yang
Journal:  Int J Nanomedicine       Date:  2015-01-22

4.  Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases.

Authors:  M Barathan; V Mariappan; E M Shankar; B J J Abdullah; K L Goh; J Vadivelu
Journal:  Cell Death Dis       Date:  2013-06-27       Impact factor: 8.469

5.  Hematoporphyrin monomethyl ether-mediated photodynamic therapy selectively kills sarcomas by inducing apoptosis.

Authors:  Hui Zeng; Mengxiong Sun; Chenghao Zhou; Fei Yin; Zhuoying Wang; Yingqi Hua; Zhengdong Cai
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

6.  St John's Wort (Hypericum perforatum L.) photomedicine: hypericin-photodynamic therapy induces metastatic melanoma cell death.

Authors:  Britta Kleemann; Benjamin Loos; Thomas J Scriba; Dirk Lang; Lester M Davids
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

Review 7.  Drug Carrier for Photodynamic Cancer Therapy.

Authors:  Tilahun Ayane Debele; Sydney Peng; Hsieh-Chih Tsai
Journal:  Int J Mol Sci       Date:  2015-09-14       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.